Revolutionary changes, both in the extent and nature of the drugs problem, and in the world in which we live, have called for constant reflection, innovation and agility to keep pace with new developments and rethink existing routines. This is why the EMCDDA has adopted a multi-indicator approach to monitoring in its response to a fast-moving drugs problem.
Čtěte více
The European Drugs Summer School (EDSS) will switch to remote teaching this year in an effort to help curb the spread of COVID-19 and reduce pressure on health services.
The 2020 EDSS — organised by the EMCDDA and the University Institute of Lisbon (ISCTE-IUL) — will run from 29 June to 10 July. Under the general theme ‘Illicit drugs in Europe: demand, supply and public policies’, the 2020 course will provide a multi-disciplinary approach to the study of the drugs problem in Europe and beyond. The focus this year will be on hepatitis C. 23.04.2020
Čtěte více
Crucial information on the impact of COVID-19 on people who use drugs, and on the services that support them, will be collected via a special round of the European Web Survey on Drugs, launched this week. The survey — the Mini European Web Survey on Drugs: COVID-19 — is coordinated by the EMCDDA in collaboration with its Reitox network of national focal points. 16.04.2020
Čtěte více
Čtěte více
